The application of Artificial Intelligence (AI) in medical imaging is reshaping the future of oncology by enabling earlier, more precise cancer detection and addressing long-standing disparities in healthcare access. Advanced machine learning and deep learning algorithms now allow radiological systems to analyze complex imaging datasets-such as X-rays, computed tomography (CT), and magnetic resonance imaging (MRI)-with unparalleled accuracy. These tools are capable of identifying minute, often imperceptible features that signal early-stage malignancies, which are frequently missed in conventional interpretation. This technological shift is instrumental in increasing survival rates and improving clinical outcomes, especially for cancers that are asymptomatic in their nascent phases. Furthermore, AI-driven imaging tools are increasingly being deployed in low-resource and remote environments, helping democratize access to high-quality diagnostics and narrowing the urban-rural healthcare divide. By facilitating scalable, remote screening and incorporating patient-specific data, these systems are also laying the groundwork for precision oncology. However, these transformative gains must be accompanied by rigorous attention to challenges such as data security, algorithmic fairness, and infrastructural readiness. This whitepaper explores the current landscape and future potential of AI-powered medical imaging, focusing on its dual promise: accelerating early cancer diagnosis and promoting global health equity.
Hugo Raposo (Mon,) studied this question.